GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.

If swallowing a horse pill in hopes of avoiding nutritional deficiencies isn’t for you, it’s understandable to be curious about vitamin patches. These mini patches, sometimes called stickers, promise ...

Losing an hour of sleep as daylight saving time kicks in can do more than leave you tired and cranky the next day — it also could harm your health ...

Add Yahoo as a preferred source to see more of our stories on Google. Hailey Bieber recently opened up about her 2022 mini-stroke incident. During her appearance on the “Therapuss with Jake Shane” ...

Hailey Bieber recently opened up about her 2022 mini-stroke incident. During her appearance on the “Therapuss with Jake Shane” podcast, the model explained how her life changed and that she became ...

Hailey Bieber has been candid about her health after suffering a mini stroke. Bieber was hospitalized in March 2022 after experiencing “stroke-like symptoms.” “It was like my tongue and my mouth could ...

“That situation made me a little bit extra hyper-aware of my body," the model, 29, said Amy Sussman/Getty Hailey Bieber reflected on her 2022 mini-stroke and subsequent heart surgery The medical ...

The risk of recurrent ischemic stroke can be reduced by managing modifiable risk factors and instituting a regimen of mechanism-specific secondary stroke prevention. Strategies for secondary ...

This article features deals sourced directly by Gizmodo and produced independently of the editorial team. We may earn a commission when you buy through links on the site. Reading time 2 minutes If you ...

GLP-1 receptor agonists may confer neuroprotection via reduced neuroinflammation, inhibited apoptosis, and vasodilatory effects that enhance cerebral perfusion through cAMP and VEGF-related pathways.

Bayer has linked asundexian to a 26% reduction in stroke in a phase 3 study, setting the bar for Bristol Myers Squibb and Johnson & Johnson’s rival factor XIa inhibitor in a blockbuster indication.